Logo image of WEED.CA

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

TSX:WEED - Toronto Stock Exchange - CA1380357048 - Common Stock - Currency: CAD

1.9  +0.1 (+5.56%)

Fundamental Rating

2

Overall WEED gets a fundamental rating of 2 out of 10. We evaluated WEED against 34 industry peers in the Pharmaceuticals industry. While WEED seems to be doing ok healthwise, there are quite some concerns on its profitability. WEED has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

WEED had negative earnings in the past year.
WEED had a negative operating cash flow in the past year.
In the past 5 years WEED always reported negative net income.
In the past 5 years WEED always reported negative operating cash flow.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

WEED has a Return On Assets of -65.18%. This is amonst the worse of the industry: WEED underperforms 82.35% of its industry peers.
The Return On Equity of WEED (-122.76%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

WEED has a Gross Margin of 30.30%. This is comparable to the rest of the industry: WEED outperforms 50.00% of its industry peers.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEED has more shares outstanding
Compared to 5 years ago, WEED has less shares outstanding
The debt/assets ratio for WEED has been reduced compared to a year ago.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

WEED has an Altman-Z score of -12.59. This is a bad value and indicates that WEED is not financially healthy and even has some risk of bankruptcy.
WEED has a Altman-Z score of -12.59. This is amonst the worse of the industry: WEED underperforms 88.24% of its industry peers.
WEED has a Debt/Equity ratio of 0.64. This is a neutral value indicating WEED is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, WEED is not doing good in the industry: 61.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -12.59
ROIC/WACCN/A
WACC11.68%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 3.12 indicates that WEED has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.12, WEED is doing good in the industry, outperforming 76.47% of the companies in the same industry.
WEED has a Quick Ratio of 2.10. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
WEED's Quick ratio of 2.10 is fine compared to the rest of the industry. WEED outperforms 79.41% of its industry peers.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 2.1
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.18% over the past year.
Looking at the last year, WEED shows a decrease in Revenue. The Revenue has decreased by -9.47% in the last year.
The Revenue has been decreasing by -7.57% on average over the past years.
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
Revenue 1Y (TTM)-9.47%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%

3.2 Future

The Earnings Per Share is expected to grow by 15.29% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.98% on average over the next years.
EPS Next Y89.5%
EPS Next 2Y38.49%
EPS Next 3Y23.41%
EPS Next 5Y15.29%
Revenue Next Year-2.01%
Revenue Next 2Y0.79%
Revenue Next 3Y7.08%
Revenue Next 5Y6.98%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

WEED's earnings are expected to grow with 23.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.49%
EPS Next 3Y23.41%

More info and screens

0

5. Dividend

5.1 Amount

WEED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANOPY GROWTH CORP

TSX:WEED (8/18/2025, 7:00:00 PM)

1.9

+0.1 (+5.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners8.19%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner ChangeN/A
Market Cap439.68M
Analysts47.69
Price Target3.26 (71.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.89%
Min EPS beat(2)-206.63%
Max EPS beat(2)-101.15%
EPS beat(4)0
Avg EPS beat(4)-194.79%
Min EPS beat(4)-240.27%
Max EPS beat(4)-101.15%
EPS beat(8)1
Avg EPS beat(8)-180.52%
EPS beat(12)1
Avg EPS beat(12)-197.59%
EPS beat(16)4
Avg EPS beat(16)-139.13%
Revenue beat(2)2
Avg Revenue beat(2)6.85%
Min Revenue beat(2)6.06%
Max Revenue beat(2)7.65%
Revenue beat(4)2
Avg Revenue beat(4)1.32%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)4.78%
Revenue beat(12)6
Avg Revenue beat(12)0.48%
Revenue beat(16)7
Avg Revenue beat(16)-2.12%
PT rev (1m)15.84%
PT rev (3m)-9.86%
EPS NQ rev (1m)-4.44%
EPS NQ rev (3m)-31.28%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-10.05%
Revenue NY rev (1m)-8.52%
Revenue NY rev (3m)-8.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.63
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 1.24
EV/EBITDA N/A
EPS(TTM)-4.28
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS1.16
BVpS2.11
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.3%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.16%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 2.1
Altman-Z -12.59
F-Score5
WACC11.68%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
EPS Next Y89.5%
EPS Next 2Y38.49%
EPS Next 3Y23.41%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-9.47%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%
Revenue Next Year-2.01%
Revenue Next 2Y0.79%
Revenue Next 3Y7.08%
Revenue Next 5Y6.98%
EBIT growth 1Y48.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.26%
EBIT Next 3Y32.93%
EBIT Next 5Y20.94%
FCF growth 1Y38.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.21%
OCF growth 3YN/A
OCF growth 5YN/A